drugset / Trial / NCT03151746

Gabapentin on Postoperative Pain Associated With Ureteroscopy and Stents Insertion

NCT03151746

Phase 4 Terminated 20 enrolled Northwestern University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The study's objective is to determine the efficacy of preoperative gabapentin in relieving postoperative pain, reducing opioid use and improving quality of recovery in subjects undergoing urologic surgery. Investigators hypothesize that subjects receiving gabapentin will have lower pain scores, less opioid consumption and better quality of recovery as compared to subjects who are given a placebo.

Timeline

Start
2018-01-14
Primary completion
2021-12-02
Completion
2021-12-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Gabapentin Small molecule 1200 mg Oral

Indications